Skip to main content
SpringerLink
Log in

Monoclonal Antibodies in Clinical and Experimental Pathology of Lung Cancer

  • Chapter
Application of Monoclonal Antibodies in Tumor Pathology

Part of the book series: Developments in Oncology ((DION,volume 50))

Abstract

Lung cancer is a major problem in oncology, since it is responsible for the highest amount of cancer deaths in western societies and shows a still rising incidence, especially among women and in developing countries (1,2). The best opportunity for curative treatment is in the first stage of disease, when cancer is limited to the lung and surgical intervention is the treatment of choice. The number of patients presenting with really limited disease is small, however, and epidemiological studies have given some indication that the overall survival will not ameliorate by screening programs set up to find such early cases (3).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Parkin DM, Stjernswärd J, Muir CS: Estimates of the worldwide frequence of twelve major cancers. Bull World Health Organ 62: 163–182, 1984.

    PubMed  CAS  Google Scholar 

  2. Stolley D: Lung cancer in women - five years later, situation worse. New Engl J Med 309: 428–429, 1983.

    Article  PubMed  CAS  Google Scholar 

  3. Early lung cancer cooperative study: Early lung cancer detection: summary and conclusions. Am Rev Respir Dis 130: 565–570, 1984.

    Google Scholar 

  4. World Health Organization: The world health organization histological typing of lung tumors, 2nd ed. Am J Clin Pathol 77: 123–136, 1982.

    Google Scholar 

  5. Yesner R: Classification of lung-cancer histology. New Engl J Med 312: 652–653, 1985.

    PubMed  CAS  Google Scholar 

  6. Elema JD, de Leij L, Postmus P, Poppema S, The TH: Critical evaluation of new techniques in the morphological diagnosis of lung cancer. In: Clinical and experimental pathology of lung cancer. McVie JG, Bakker W, Wagenaar SjSc, Carney D (eds). The Hague, Martinus Nijhoff, pp 91–103, 1986.

    Chapter  Google Scholar 

  7. Greco FA, Oldham RK: Current concepts in cancer. Small-cell lung cancer. New Engl J Med 301: 355–358, 1979.

    Article  PubMed  CAS  Google Scholar 

  8. de Leij L, Postmus PE, Buys Ch, Elema JD, Poppema S, Brouwer M, Ramaekers F, van der Veen A, Mesander G, The TH: Characterization of three new “variant type” SCLC derived cell lines. Cancer Res 45: 6024–6034, 1985.

    PubMed  Google Scholar 

  9. Baylin SB, Mendelsohn G: Time dependent changes in human tumors: Implications for diagnosis and clinical behaviour. Semin Oncol 9: 504–512, 1982.

    PubMed  CAS  Google Scholar 

  10. Carney DN, Mitchell JB, Kinsella TJ: In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variants. Cancer Res 43: 2806–2811, 1983.

    PubMed  CAS  Google Scholar 

  11. Gazdar A, Carney DN, Guccion J, Baylin S: Small cell carcinoma of the lung: cellular origin and relationship to other pulmonary tumors. In: Small cell lung cancer. Greco F, Oldham R, Bunn P (eds). New York, Grune and Stratton, pp 145–176, 1981.

    Google Scholar 

  12. Baylin SB, Gazdar AF, Minna JD, Bernal SD, Shaper JH: A unique cell-surface protein phenotype distinguishes human small cell from non small cell lung cancer. Proc Natl Acad Sci USA 79: 4650–4654, 1982.

    Article  PubMed  CAS  Google Scholar 

  13. Goodwin G, Shaper JH, Abeloff MD, Mendelsohn G, Baylin SB: Analysis of cell surface proteins delineates a differentiation pathway linking endocrine and nonendocrine human lung cancers. Proc Natl Acad Sci USA 80: 3807–3811, 1983.

    Article  PubMed  CAS  Google Scholar 

  14. Bergh J, Nilsson K, Cate CC, Pettengill O, Sorenson GD: Cell surface glycoprotein patterns of cell lines derived from human small cell carcinoma of the lung. Acta Path Microbiol Scand Sect A 91: 9–15, 1983.

    CAS  Google Scholar 

  15. Bernal SD, Baylin SB, Shaper JH, Gazdar AF, Chen LB: Cytoskeleton-associated proteins of human lung cancer cells. Cancer Res 43: 1798–1808, 1983.

    PubMed  CAS  Google Scholar 

  16. De Schrijver-Kecskemeti K, Kyriakos M, Bell CE, Seetharam S: Pulmonary oat cell carcinoma. Expression of plasma membrane antigen correlated with presence of cytoplasmic neurosecretory granules. Lab Invest 41: 432–436, 1979.

    Google Scholar 

  17. Bell CE, Seetharam S, McDaniel RC: Endodermally derived and neural crest derived differentiation antigens expressed by a human lung tumor. J Immunol 116: 1236–1243, 1976.

    PubMed  Google Scholar 

  18. Bell CE, Seetharam S: Identification of the Schwann cell as a peripheral nervous system cell possessing a differentiation antigen expressed by a human lung tumor. J Immunol 118: 826–831, 1977.

    PubMed  Google Scholar 

  19. De Leij L, Poppema S, Klein Nulend J, ter Haar A, Schwander E, Ebbens F, Postmus PE, The TH: Neuroendocrine differentiation antigen on human lung carcinoma and Kulchitski cells. Cancer Res 45: 2192–2200, 1985.

    PubMed  Google Scholar 

  20. Stahel RA, Speak JA, Bernal SD: Murine monoclonal antibody LAM2 defines cell membrane determinant with preferential expression on human lung small cell carcinoma and squamous cell carcinomas. Int J Cancer 35: 11–17, 1985.

    Article  PubMed  CAS  Google Scholar 

  21. Tong AW, Lee J, Stone MJ: Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach. Cancer Res 44: 4987–4992, 1984.

    PubMed  CAS  Google Scholar 

  22. Okaba T, Kaizu T, Fujisawa M, Watanaba J, Koyoko K, Yamashita T, Takaku F: Monoclonal antibodies to surface antigens of small cell carcinoma of the lung. Cancer Res 44: 5273–5278, 1984.

    Google Scholar 

  23. Rosen ST, Mulshine JL, Cuttitta F, Fedorko J, Carney DN, Gazdar AF, Minna JD: Analysis of human small cell lung cancer differentiation antigens using a panel of rat monoclonal antibodies. Cancer Res 44: 2052–2061, 1984.

    PubMed  CAS  Google Scholar 

  24. Ball HD, Graziano RF, Pettengill OS, Sorenson GD, Fanger MW: Monoclonal antibodies reactive with small cell carcinoma of the lung. J Natl Cancer Inst 72: 593–598, 1984.

    PubMed  CAS  Google Scholar 

  25. Bernal SD, Speak JA: Membrane antigen in small cell carcinoma of the lung defined by monoclonal antibody. Cancer Res 44: 265–270, 1984.

    PubMed  CAS  Google Scholar 

  26. Stahel RA, O’Hara CJ, Mabry M, Waibel R, Sabbath K, Speak JA, Bernal SD: Cytotoxic murine monoclonal antibody LAM8 with specificity for human small cell carcinoma of the lung. Cancer Res 46: 2077–2084, 1986.

    PubMed  CAS  Google Scholar 

  27. Brenner BG, Jothy S, Shuster J, Fuks A: Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation. Cancer Res 42: 3187–3192, 1982.

    PubMed  CAS  Google Scholar 

  28. Kyoizumi S, Akiyama M, Kouno N, Kobuka K, Hakado M, Jones SK, Yamakido M: Monoclonal antibodies to human squamous cell carcinoma of the lung and their application to tumor diagnosis. Cancer Res 45: 3274–3281, 1985.

    PubMed  CAS  Google Scholar 

  29. Brown DT, Moore M: Monoclonal antibodies against two human lung carcinoma cell lines. Br J Cancer 46: 794–801, 1982.

    Article  PubMed  CAS  Google Scholar 

  30. Yarki NM, Reisfeld RH, Walker LE: Antigens associated with a human lung adenocarcinoma defined by monoclonal antibodies. Cancer Res 44: 681–687, 1984.

    Google Scholar 

  31. Mulshine JL, Cuttitta F, Bibro M, Fedorko J, Fargion S, Little C, Carney DN, Gazdar AF, Minna JD: Monoclonal antibodies that distinguish non-small cell from small cell lung cancer. J Immunol 131: 497–502, 1983.

    PubMed  CAS  Google Scholar 

  32. Mazauric T, Mitchell KF, Letchworth GJ, Koprowski H, Steplewski Z: Monoclonal antibody defined human lung cell surface protein antigens. Cancer Res 42: 150–154, 1982.

    PubMed  CAS  Google Scholar 

  33. Radosevich JA, Ma Y, Lee I, Salwen HR, Gould YE, Rosen ST: Monoclonal antibody 44-3A6 as a probe for a novel antigen found on human lung carcinomas with glandular differentiation. Cancer Res 45: 5808–5812, 1985.

    PubMed  CAS  Google Scholar 

  34. Sobol RE, Astarita RW, Cook-Hinds T, Burton D, Falco M, Masui H, Handley HH, Royston I: A monoclonal antibody reactive with a subset of human lung carcinomas. Clinical Res 31: 412A, 1983.

    Google Scholar 

  35. Bunn PA, Linnoila I, Minna JD, Carney D, Gazdar AF: Small cell lung cancer, endocrine cells of the fetal bronchus and other neuroendocrine cells express the leu-7 antigenic determinant present on natural killer cells. Blood 65: 764–768, 1985.

    PubMed  Google Scholar 

  36. Ball ED, Sorenson GD, Pettengill OS: Expression of myeloid and major histocompatibility antigens on small cell carcinoma of the lung cell lines analyzed by cytofluorography: modulation by -interferon. Cancer Res 46: 2335–2339, 1986.

    PubMed  CAS  Google Scholar 

  37. Cole SPC, Mirski S, McGarry RC, Cheng R, Campling BG, Roder JC: Differential expression of the leu-7 antigen on human lung tumor cells. Cancer Res 45: 4285–4290, 1985.

    PubMed  CAS  Google Scholar 

  38. Marangos PJ, Carney DN, Polak JM, Pearse AGE: Neuron specific enolase and small cell cancer of the lung. In: The endocrine lung in health and disease. Becker KL, Gazdar AF (eds), WB Saunders Company, Philadelphia pp 509–515, 1984.

    Google Scholar 

  39. Thomas P, Battifore H, Manderino G: Is neuron-specific enolase specific? An immunohistochemical comparison of a monoclonal and a polyclonal antibody against neuron-specific enolase. Lab Invest 54: 63A, 1984.

    Google Scholar 

  40. Kumar NB, Cookingham CL, Lloyd RV, Appelman HD: Detection of human chromogranin with a monoclonal antibody in carcinoid secretory granules and its comparison with the generic silver stains and with serotonin. Lab Invest 50: 33A, 1984.

    Google Scholar 

  41. Wiedemann B, Franke WW, Kuhn C, Moll R, Gould VE: Synaptophysin: a marker protein for neuroendocrine cells and neoplasms. Proc Natl Acad Sci USA 83: 3500–3504, 1986.

    Article  Google Scholar 

  42. Allan PM, Garson JA, Harper EI, Asser U, Coakham HB, Brownell B, Kemshead JT: Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues. Int J Cancer 31: 591–598, 1983.

    Article  PubMed  CAS  Google Scholar 

  43. Lehto Y-P, Stenman S, Miettinen M, Dahl D, Yirtanen I: Expression of a neural type of intermediate filament as a distinguishing feature between oat cell carcinoma and other lung cancers. Am J Pathol 110: 113–118, 1983.

    PubMed  CAS  Google Scholar 

  44. Broers J, Huijsmans A, Moesker O, Yooijs P, Ramaekers F, Wagenaar S: Small cell lung cancers contain intermediate filaments of the cytokeratin type. Lab Invest 52: 113–115, 1985.

    PubMed  CAS  Google Scholar 

  45. Blobel G, Gould YE, Moll R, Lee I, Huszar M, Geiger B, Franke WW: Co-expression of neuroendocrine markers and epithelial cytoskeletal proteins in bronchopulmonary neuroendocrine neoplasms. Lab Invest 52: 39–51, 1985.

    PubMed  CAS  Google Scholar 

  46. Bensch KG, Corrin B, Pariente R, Spencer H: Oat-cell carcinoma of the lung: its origin and relationship to bronchial carcinoid. Cancer 22: 1163–1172; 1968.

    Article  PubMed  CAS  Google Scholar 

  47. Moll R, Moll I, Franke WW: Identification of Merkel cells in human skin by specific cytokeratin antibodies: changes of cell density and distribution in fetal and adult plantar epidermis. Differentiation 28: 136–154, 1984.

    Article  PubMed  CAS  Google Scholar 

  48. van Muyen NF, Ruiter DJ, van Leeuwen C, Prins FA, Rietsema K, Warnaar SO: Cytokeratin and neurofilament in lung carcinomas. Am J Pathol 116: 363–369, 1984.

    Google Scholar 

  49. Kahn HJ, Garrido A, Huang SN, Baumal R: Intermediate filaments and tumor diagnosis. Lab Invest 49: 509–510, 1983.

    Google Scholar 

  50. Lehto V-P, Miettinen M, Virtanen I: A dual expression of cytokeratin and neurofilaments in bronchial carcinoid cells. Int J Cancer 35: 421–425, 1985.

    Article  PubMed  CAS  Google Scholar 

  51. de Leij L, Postmus PE, Poppema S, Elema JD, The TH: The use of monoclonal antibodies for the pathological diagnosis of lung cancer. In: Lung cancer: basic and clinical aspects. Hansen HH (ed). The Hague, Martinus Nijhoff, pp 31–48, 1986.

    Google Scholar 

  52. Stahlman MT, Gray ME: Ontogeny of neuroendocrine cells in human fetal lung. I. An electron microscopic study. Lab Invest 51: 449–463, 1984.

    PubMed  CAS  Google Scholar 

  53. Broers J, Carney D, de Leij L, Vooys G, Ramaekers F: Differential expression of intermediate filament proteins distinguishes classic from variant small cell lung cancer cell lines. Proc Natl Acad Sci USA 82: 4409–4413, 1985.

    Article  PubMed  CAS  Google Scholar 

  54. de Leij L, Poppema S, Klein Nulend J, ter Haar JG, Schwander E, The TH: Immunoperoxidase staining on frozen tissue sections as a first screening assay in the preparation of monoclonal antibodies directed against small cell carcinoma of the lung. Eur J Cancer Clin Oncol 20: 123–128, 1984.

    Article  PubMed  Google Scholar 

  55. Broers JLY, Carney DN, Klein Rot M, Schaart G, Lane EB, Vooijs GP, Ramaekers FCS: Intermediate filament proteins in classic- and variant- type small cell lung carcinoma cell lines. A biochemical and immunochemical analysis using a panel of monoclonal and polyclonal antibodies. J Cell Sc 1986, in press.

    Google Scholar 

  56. Ramaekers F, Huijsmans A, Moesker O, Kant A, Jap P, Herman C, Vooijs P: Monoclonal antibodies to keratin filaments, specific for glandular epithelia and their tumors. Use in surgical pathology. Lab Invest 49: 353–361, 1983.

    PubMed  CAS  Google Scholar 

  57. Ramaekers F, Puts J, Moesker O, Kant A, Huijsmans A, Haag D, Jap P, Herman C, Vooijs G: Antibodies to intermediate filament proteins in immunohistochemical identification of human tumors: an overview. Histochem J 15: 691–713, 1983.

    Article  PubMed  CAS  Google Scholar 

  58. Klük P, van Muyen GNP, van der Kamp AWM, Tibboel D, van Hoorn WA, Warnaar SO, Molenaar JC: Hirschsprung’s disease studied with monoclonal antineurofilament antibodies on tissue sections. Lancet i: 652–654, 1984.

    Article  Google Scholar 

  59. Sehested M, Hirsch FR, Hou-Jensen K: Immunoperoxidase staining for carcinoembryonic antigen in small cell carcinoma of the lung. Eur J Cancer Clin Oncol 17: 1125–1131, 1981.

    Article  PubMed  CAS  Google Scholar 

  60. Hammond ME, Sause WT: Large cell neuroendocrine tumors of the lung. Clinical significance and histopathologic definition. Cancer 56: 1624–1629, 1985.

    Article  PubMed  CAS  Google Scholar 

  61. Carney DN, Gazdar AF, Bepler G, Guccion JG, Marangos PJ, Moody TW, Zweig MH, Minna JD: Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res 45: 2913–2923, 1985.

    PubMed  CAS  Google Scholar 

  62. Gazdar AF, Carney DN, Nau MM, Minna JD: Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. Cancer Res 45: 2924–2930, 1985.

    PubMed  CAS  Google Scholar 

  63. Hirsch FR, Osterlind K, Hansen HH: The prognostic significance of histopathological subtyping of small cell carcinoma of the lung according to the World Health Organization. Cancer 52: 2144–2150, 1983.

    Article  PubMed  CAS  Google Scholar 

  64. Gould VE, Moll R, Moll I, Lee I, Franke WW: Neuroendocrine (Merkel) cells of the skin: hyperplasias, dysplasias, and neoplasias. Lab Invest 52: 334–353, 1985.

    PubMed  CAS  Google Scholar 

  65. Miettinen M, Lehto Y-P, Dahl D, Virtanen I: Varying expression of cytokeratin and neurofilaments in neuroendocrine tumors of human gastrointestinal tract. Lab Invest 52: 429–436, 1985.

    PubMed  CAS  Google Scholar 

  66. Jasani B, Edwards RE, Thomas ND, Gibbs AR: The use of vimentinantibodies in the diagnosis of malignant mesotheliomas. Virch Arch [Pathol Anat] 406: 441–448, 1985.

    Article  CAS  Google Scholar 

  67. Gatter KC, Dunnhill MS, Muyen GNP van, Mason DY: Human lung tumours may co-express different classes of intermediate filaments. J Clin Pathol, in press, 1986.

    Google Scholar 

Download references

Authors
  1. L. De Leij
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Broers
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Ramaekers
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Berendsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sj. Sc. Wagenaar
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology, University Medical Center, Nijmegen, The Netherlands

    Dirk J. Ruiter

  2. Department of Pathology, University Medical Center, Leiden, The Netherlands

    Gert Jan Fleuren  & Sven O. Warnaar  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Martinus Nijhoff Publishers, Dordrecht

About this chapter

Cite this chapter

De Leij, L., Broers, J., Ramaekers, F., Berendsen, H., Wagenaar, S.S. (1987). Monoclonal Antibodies in Clinical and Experimental Pathology of Lung Cancer. In: Ruiter, D.J., Fleuren, G.J., Warnaar, S.O. (eds) Application of Monoclonal Antibodies in Tumor Pathology. Developments in Oncology, vol 50. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3299-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-3299-9_10

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7981-5

  • Online ISBN: 978-94-009-3299-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation